Educational Opportunities

This course includes: 

• Video presentation by a leading expert
• Pre- and post-exams to measure your understanding
• Downloadable slides
• CME and MOC claiming online

Ghada Fuleihan, MD, MPH

Ghada El-Hajj Fuleihan, MD, MPH, FRCP, is Professor of Medicine, founding Director of the Calcium Metabolism and Osteoporosis Program, WHO Collaborating Center for Metabolic Bone Disorders, and of the Scholars in HeAlth Research Program at the American University of Beirut, Beirut, Lebanon. Dr. El-Hajj Fuleihan obtained her medical degree from the American University of Beirut (AUB), completed her residency and fellowship at the New England Deaconess and Brigham and Women’s Hospitals, Harvard Medical School, Boston. She holds a master's degree in Public Health, from the Harvard T.H. Chan School of Public Health. Dr. El-Hajj Fuleihan’s laboratory focuses on generating evidence on the pathophysiology, prevention, and treatment of hypovitaminosis D, osteoporosis, and other metabolic bone disorders through clinical trials, systematic reviews, and meta-analyses, and translating findings into prevention and treatment strategies. She closely collaborates with the ministry of health officials and international experts to generate evidence-based national and international care pathways and guidelines on metabolic bone diseases (see publications). She has mentored over 60 trainees, including 8 medical students, 14 MSc and PhD students, and 37 post-doc MDs. Dr. El-Hajj Fuleihan is a member of the Alpha Omega Alpha Medical Honor Society, and recipient of several awards. These include the 2013 International Society of Clinical Densitometry John P. Bilezikian Global Leadership Award, the 2016 Endocrine Society International Excellence in Endocrinology Laureate Award, and the 2017 Harvard T. Chan School of Public Health Award of Merit. She holds a lifelong appointment as the Bernard Lown Scholar in the Department of Global Health and Population, at the Harvard T.H. Chan School of Public Health. 

LEARNING OBJECTIVES

Upon completion of this activity, learners will be able to:

• Review the clinical presentation of diabetic bone disease
• Understand the pathophysiology of diabetic bone disease
• Determine the efficacy and safety of osteoporosis drugs in diabetic bone disease

MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity enables the participant to earn up to .75 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points. 

Your participation information will be shared with the ACCME, which will in turn report your points to ABIM. Successful completion of a course examination is required to earn ABIM MOC points.

ACCREDITATION AND DESIGNATION STATEMENTS

The American Association of Clinical Endocrinologists (AACE) is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The American Association of Clinical Endocrinologists (AACE) designates this live activity for a maximum of .75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.